{"id":"pantoprazole-controloc","safety":{"commonSideEffects":[{"rate":"12","effect":"Headache"},{"rate":"8","effect":"Diarrhea"},{"rate":"7","effect":"Nausea"},{"rate":"6","effect":"Abdominal pain"},{"rate":"4","effect":"Flatulence"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Pantoprazole is a proton pump inhibitor (PPI) that binds to and inactivates the H+/K+-ATPase enzyme on the secretory surface of gastric parietal cells. This blocks the final step of gastric acid production, significantly reducing intragastric acidity. It is used to treat acid-related disorders by maintaining elevated gastric pH.","oneSentence":"Pantoprazole irreversibly inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:35:40.674Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gastroesophageal reflux disease (GERD)"},{"name":"Peptic ulcer disease"},{"name":"Zollinger-Ellison syndrome"},{"name":"Prophylaxis of acid aspiration during anesthesia"}]},"trialDetails":[{"nctId":"NCT02685748","phase":"PHASE2, PHASE3","title":"Aspirin in Young Psychotic Patients","status":"COMPLETED","sponsor":"Clinic for Psychiatric Disorders, Dr Laza Lazarevic","startDate":"2017-07-20","conditions":"Psychosis, Acute Psychosis, Schizophrenia","enrollment":60},{"nctId":"NCT05227833","phase":"PHASE3","title":"Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-02-15","conditions":"Portal Hypertension, Variceal Hemorrhage, Ulcer Hemorrhage","enrollment":284},{"nctId":"NCT06414707","phase":"PHASE3","title":"Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-10-12","conditions":"Helicobacter Pylori Infection","enrollment":320},{"nctId":"NCT00825630","phase":"PHASE4","title":"13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)","status":"COMPLETED","sponsor":"Meridian Bioscience, Inc.","startDate":"2008-11","conditions":"Helicobacter Pylori Infection","enrollment":123},{"nctId":"NCT04217512","phase":"PHASE3","title":"Pantoprazole in Cisplatin Nephrotoxicity","status":"RECRUITING","sponsor":"Sherief Abd-Elsalam","startDate":"2019-05-01","conditions":"Oncology","enrollment":60},{"nctId":"NCT02788123","phase":"PHASE4","title":"A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy","status":"TERMINATED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2017-03-03","conditions":"NSAID-induced Gastropathy","enrollment":9},{"nctId":"NCT01016717","phase":"PHASE4","title":"Clopidogrel Proton-Pump Inhibitors Study","status":"WITHDRAWN","sponsor":"Sheba Medical Center","startDate":"2012-12","conditions":"Coronary Artery Disease","enrollment":""},{"nctId":"NCT01281501","phase":"PHASE4","title":"Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2011-01","conditions":"Dyspepsia, Emergency, Pain","enrollment":87}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION"}],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Controloc"],"phase":"marketed","status":"active","brandName":"Pantoprazole(Controloc)","genericName":"Pantoprazole(Controloc)","companyName":"Meridian Bioscience, Inc.","companyId":"meridian-bioscience-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pantoprazole irreversibly inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion. Used for Gastroesophageal reflux disease (GERD), Peptic ulcer disease, Zollinger-Ellison syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}